In August 2022, the American Heart Association released a statement outlining new recommended guidelines for managing infective endocarditis in people who inject drugs, providing a timely and comprehensive approach to the management of the disease than what was previously provided by the AHA. With the incidences of infective endocarditis cases among people who inject drugs […]
Division of Infectious Diseases’ Laura Marks, MD, PhD, contributes to American Heart Association statement on injective drug use infective endocarditis; WashU oral therapy research supports new guidelines















































